ATE251894T1 - Pharmazeutische zusammensetzungen zur oralen verabreichung - Google Patents

Pharmazeutische zusammensetzungen zur oralen verabreichung

Info

Publication number
ATE251894T1
ATE251894T1 AT00993686T AT00993686T ATE251894T1 AT E251894 T1 ATE251894 T1 AT E251894T1 AT 00993686 T AT00993686 T AT 00993686T AT 00993686 T AT00993686 T AT 00993686T AT E251894 T1 ATE251894 T1 AT E251894T1
Authority
AT
Austria
Prior art keywords
oral administration
active principle
vesicles
pharmaceutical compositions
solution
Prior art date
Application number
AT00993686T
Other languages
English (en)
Inventor
Charles Guinez
Rene Laversanne
Jo Lle Amedee
Original Assignee
Capsulis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsulis filed Critical Capsulis
Application granted granted Critical
Publication of ATE251894T1 publication Critical patent/ATE251894T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00993686T 2000-01-03 2000-12-27 Pharmazeutische zusammensetzungen zur oralen verabreichung ATE251894T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000015A FR2803202B1 (fr) 2000-01-03 2000-01-03 Compositions pharmaceutiques destinees a une adminstration par voie orale
PCT/FR2000/003692 WO2001049264A2 (fr) 2000-01-03 2000-12-27 Compositions pharmaceutiques destinees a une administration par voie orale

Publications (1)

Publication Number Publication Date
ATE251894T1 true ATE251894T1 (de) 2003-11-15

Family

ID=8845578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00993686T ATE251894T1 (de) 2000-01-03 2000-12-27 Pharmazeutische zusammensetzungen zur oralen verabreichung

Country Status (10)

Country Link
US (1) US6770292B2 (de)
EP (1) EP1244427B1 (de)
JP (1) JP2004506600A (de)
AT (1) ATE251894T1 (de)
AU (1) AU780548B2 (de)
CA (1) CA2396379A1 (de)
DE (1) DE60006000T2 (de)
ES (1) ES2210035T3 (de)
FR (1) FR2803202B1 (de)
WO (1) WO2001049264A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842734A1 (fr) * 2002-07-24 2004-01-30 Ethypharm Sa Procede pour diminuer la variabilite de la biodisponibilite d'un medicament a administration orale et compositions pharmaceutiques a administration orale
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
CA2563533C (en) * 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
US8449979B2 (en) 2005-01-28 2013-05-28 Japan Science And Technology Agency Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof
KR101814186B1 (ko) 2008-09-17 2018-03-14 키아스마 인코포레이티드 약제학적 조성물 및 연관된 투여방법
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
CN108403664B (zh) * 2018-03-16 2020-02-18 武汉百纳礼康生物制药有限公司 一种可包载不同极性药物的液晶凝胶纳米粒及其制备方法
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
US6290987B1 (en) * 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids

Also Published As

Publication number Publication date
WO2001049264A2 (fr) 2001-07-12
FR2803202A1 (fr) 2001-07-06
US6770292B2 (en) 2004-08-03
ES2210035T3 (es) 2004-07-01
DE60006000T2 (de) 2004-07-29
EP1244427B1 (de) 2003-10-15
JP2004506600A (ja) 2004-03-04
WO2001049264A3 (fr) 2002-03-14
FR2803202B1 (fr) 2004-04-16
DE60006000D1 (de) 2003-11-20
CA2396379A1 (en) 2001-07-12
EP1244427A2 (de) 2002-10-02
AU2859801A (en) 2001-07-16
US20030072797A1 (en) 2003-04-17
AU780548B2 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
SE9600071D0 (sv) New oral formulation of two active ingredients I
WO2001068138A3 (en) Intradermal-penetration agents for topical local anesthetic administration
DE69636413D1 (de) Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe
DE60312523D1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
CY1112510T1 (el) Φαρμακευτικο παρασκευασμα υπο τη μορφη παστας το οποιο περιεχει ενα ασταθες στα οξεα δραστικο συστατικο
AR037256A1 (es) Forma de dosificacion de liberacion controlada dual
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
SE9503143D0 (sv) New preparation
AR018109A1 (es) FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA
UA29469C2 (uk) Ліпосомальна фармацевтична композиція для внутрішньовенного введення
SE9600072D0 (sv) New oral formulation of two active ingredients II
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
EP1365749A4 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
NO306894B1 (no) Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet
ATE251894T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung
EP1285667A3 (de) Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
KR880009634A (ko) 슈도에페드린 브롬페니라민 요법의 개량
ITMI20020189A1 (it) Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
BR9913135A (pt) Formulação oral
ATE260643T1 (de) System zur verabreichung makromolekularer wirkstoffe auf der basis von membran-mimetischen amphiphilen in aerosolform
AU2002215944A1 (en) Film for active ingredients dermal and transdermal administration
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties